Early Temporary SCS Prevents Postherpetic Neuralgia

  • Registration Closed

Review the journal article and assessment of the paper, Early Treatment with Temporary Spinal Cord Stimulation Effectively Prevents Development of Postherpetic Neuralgia, which was critically reviewed by SIS Research Division member Jeremy Beckworth, MD.

Once you review the article and assessment, you will be asked to complete a quiz to earn continuing medical education (CME) credits.

Fair Use Disclaimer
This article is made available for the purpose of this online continuing medical education activity under the fair use doctrine of copyright law, which allows that the use of a copyrighted work “for purposes such as criticism, comment, news reporting, teaching (including multiple copies for classroom use), scholarship, or research, is not an infringement of copyright” and factors to consider are “the purpose and character of the use, including whether such use is of a commercial nature or is for nonprofit educational purposes” Section 107 of the Copyright Act.

Copyright
Materials presented in this activity have been made available by the Spine Intervention Society for educational purposes only. We reserve all rights to such material.

Educational Objectives
Upon completion of this activity, participants should be able to:

  • Examine emerging literature to mitigate risks and to practice pain interventions safely to best protect patients
  • Discuss the application of evidence-based medicine principles to recent research findings
  • Apply research findings to the practice of ethical, evidence-based interventional pain care

Disclosure Information
RELEVANT FINANCIAL RELATIONSHIPS WITH ACCME DEFINED COMMERCIAL INTERESTS
Jeremy Beckworth, MD
Nothing to disclose

OTHER DISCLOSURES
Jeremy Beckworth, MD
Research grant: Mesoblast Inc.

Accreditation Statement
The Spine Intervention Society (SIS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
SIS designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
No commercial support was received for this activity.

Date of Activity Release: 6/24/2020 
Date of Activity Expiration: 6/23/2023

Components visible upon registration.